Fringe movements are using games and other online platforms to draw growing numbers of children to their causes, new data and dozens of interviews show.

In a report released on January 14, Evan Seigerman from BMO Capital reiterated a Hold rating on Replimune Group, with a price target of $11.00. The company’s shares closed yesterday at $7.71.

Here's what a neti pot is, when to use one and how to do so safely.

Two websites that distribute instructions for how to manufacture ghost guns are facing a new lawsuit from the state of ...

The Tribunal held that where income is offered to tax on receipt basis, TDS credit must be granted in the same year despite timing differences arising from accrual-based deduction by ...

Veronika, a cow living in an idyllic mountain village in the Austrian countryside, has spent years perfecting the art of scratching herself with sticks, rakes, and deck brushes. Now that scientists ...

Both new municipal mayors last fall promised more joint city council/borough assembly meetings. They’re off to a quick start, with the first one scheduled for next Tuesday.

Artificial Intelligence is everywhere, from shopping assistants on Amazon, to replacing search engines like Google. While ChatGPT might make it easy to put together a shopping list or travel plans, it ...

Second-round debate on Legislative Bill 538 paused Friday after Omaha Sen. Megan Hunt accused Gering Sen. Brian Hardin of ...

The Legislature Monday advanced North Platte Sen. Mike Jacobson's Legislative Bill 719, clarifying the use of Hershey rail park funds, and Whitman Sen. Tanya Storer's LB 663 on livestock permits.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...